...
abos-img

Acumen Pharmaceuticals Inc, Common Stock

ABOS

NSQ

$1.79

+$0.02

(1.13%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$107.54M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.72 L
$5.09 H
$1.79

About Acumen Pharmaceuticals Inc, Common Stock

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameABOSSectorS&P500
1-Week Return-8.67%-0.33%-1.49%
1-Month Return-24.15%-4.57%-0.37%
3-Month Return-26.64%-9.96%3.89%
6-Month Return-20.09%-5.67%9.34%
1-Year Return-51.62%2.53%25.19%
3-Year Return-73.79%-1.43%24.7%
5-Year Return-91.09%34.73%85.39%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue1.70M1.44M1.44M--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.62,"profit":true},{"date":"2021-12-31","value":84.62,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue8.58K8.00K4.00K169.00K42.32M[{"date":"2019-12-31","value":0.02,"profit":true},{"date":"2020-12-31","value":0.02,"profit":true},{"date":"2021-12-31","value":0.01,"profit":true},{"date":"2022-12-31","value":0.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit1.69M1.43M(4.00K)(169.00K)(42.32M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":84.58,"profit":true},{"date":"2021-12-31","value":-0.24,"profit":false},{"date":"2022-12-31","value":-10.01,"profit":false},{"date":"2023-12-31","value":-2506.36,"profit":false}]
Gross Margin99.49%99.44%(0.28%)--[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.95,"profit":true},{"date":"2021-12-31","value":-0.28,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses9.50M9.35M19.58M45.24M61.14M[{"date":"2019-12-31","value":15.54,"profit":true},{"date":"2020-12-31","value":15.29,"profit":true},{"date":"2021-12-31","value":32.03,"profit":true},{"date":"2022-12-31","value":73.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(7.80M)(7.91M)61.57M(45.24M)(61.14M)[{"date":"2019-12-31","value":-12.68,"profit":false},{"date":"2020-12-31","value":-12.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-73.47,"profit":false},{"date":"2023-12-31","value":-99.29,"profit":false}]
Total Non-Operating Income/Expense(57.00K)588.00K(80.94M)4.77M17.00M[{"date":"2019-12-31","value":-0.34,"profit":false},{"date":"2020-12-31","value":3.46,"profit":true},{"date":"2021-12-31","value":-476.13,"profit":false},{"date":"2022-12-31","value":28.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(7.91M)(7.33M)(100.61M)(42.86M)(52.37M)[{"date":"2019-12-31","value":-790700000,"profit":false},{"date":"2020-12-31","value":-732500000,"profit":false},{"date":"2021-12-31","value":-10060600000,"profit":false},{"date":"2022-12-31","value":-4285600000,"profit":false},{"date":"2023-12-31","value":-5237100000,"profit":false}]
Income Taxes(45.00K)(1.00K)81.07M(2.38M)-[{"date":"2019-12-31","value":-0.06,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.94,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(7.86M)(7.32M)(181.68M)(40.48M)-[{"date":"2019-12-31","value":-786200000,"profit":false},{"date":"2020-12-31","value":-732400000,"profit":false},{"date":"2021-12-31","value":-18167900000,"profit":false},{"date":"2022-12-31","value":-4047500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(7.91M)(7.33M)(100.61M)(42.86M)(48.74M)[{"date":"2019-12-31","value":-790700000,"profit":false},{"date":"2020-12-31","value":-732500000,"profit":false},{"date":"2021-12-31","value":-10060600000,"profit":false},{"date":"2022-12-31","value":-4285600000,"profit":false},{"date":"2023-12-31","value":-4874000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.86M)(7.32M)(181.68M)(40.48M)(52.37M)[{"date":"2019-12-31","value":-786200000,"profit":false},{"date":"2020-12-31","value":-732400000,"profit":false},{"date":"2021-12-31","value":-18167900000,"profit":false},{"date":"2022-12-31","value":-4047500000,"profit":false},{"date":"2023-12-31","value":-5237100000,"profit":false}]
EPS (Diluted)(4.88)(64.40)(9.37)(1.06)(1.08)[{"date":"2019-12-31","value":-487.81,"profit":false},{"date":"2020-12-31","value":-6439.85,"profit":false},{"date":"2021-12-31","value":-937,"profit":false},{"date":"2022-12-31","value":-106,"profit":false},{"date":"2023-12-31","value":-108,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ABOS
Cash Ratio 10.06
Current Ratio 10.43

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABOS
ROA (LTM) -20.99%
ROE (LTM) -32.83%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABOS
Debt Ratio Lower is generally better. Negative is bad. 0.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.81

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABOS
Trailing PE NM
Forward PE NM
P/S (TTM) 538.78
P/B 0.50
Price/FCF NM
EV/R 89.67
EV/Ebitda NM

FAQs

What is Acumen Pharmaceuticals Inc share price today?

Acumen Pharmaceuticals Inc (ABOS) share price today is $1.79

Can Indians buy Acumen Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Acumen Pharmaceuticals Inc (ABOS) on Vested. To buy Acumen Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABOS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Acumen Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Acumen Pharmaceuticals Inc (ABOS) via the Vested app. You can start investing in Acumen Pharmaceuticals Inc (ABOS) with a minimum investment of $1.

How to invest in Acumen Pharmaceuticals Inc shares from India?

You can invest in shares of Acumen Pharmaceuticals Inc (ABOS) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABOS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Acumen Pharmaceuticals Inc shares
What is Acumen Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Acumen Pharmaceuticals Inc (ABOS) is $5.09. The 52-week low price of Acumen Pharmaceuticals Inc (ABOS) is $1.72.

What is Acumen Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Acumen Pharmaceuticals Inc (ABOS) is

What is Acumen Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Acumen Pharmaceuticals Inc (ABOS) is 0.50

What is Acumen Pharmaceuticals Inc dividend yield?

The dividend yield of Acumen Pharmaceuticals Inc (ABOS) is 0.00%

What is the Market Cap of Acumen Pharmaceuticals Inc?

The market capitalization of Acumen Pharmaceuticals Inc (ABOS) is $107.54M

What is Acumen Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Acumen Pharmaceuticals Inc is ABOS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top